{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:02:27Z","timestamp":1755223347427,"version":"3.43.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89826","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:40:42Z","timestamp":1754934042000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperhomocysteinemia: A Predictor of Microvascular Complications in Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Shali","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalakrishna","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namitha","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheejamol","family":"VS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetes mellitus: complications","author":"Powers AC","year":"2022","unstructured":"Powers AC, Stafford JM, Rickels MR. Diabetes mellitus: complications. Harrison's Principles of Internal Medicine. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J (ed): McGraw-Hill Education, 2022. 3120."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107834","article-title":"Homocysteine and diabetes: role in macrovascular and microvascular complications","volume":"35","author":"Muzurovi\u0107 E","year":"2021","unstructured":"Muzurovi\u0107 E, Kraljevi\u0107 I, Solak M, Dragni\u0107 S, Mikhailidis DP. Homocysteine and diabetes: role in macrovascular and microvascular complications. J Diabetes Complications. 2021, 35:107834. 10.1016\/j.jdiacomp.2020.107834","journal-title":"J Diabetes Complications"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey CJ","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995, 274:1049-57. 10.1001\/jama.1995.03530130055028","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0026-0495(99)90121-x","article-title":"Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus","volume":"48","author":"Stabler SP","year":"1999","unstructured":"Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW. Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism. 1999, 48:1096-101. 10.1016\/s0026-0495(99)90121-x","journal-title":"Metabolism"},{"key":"ref5","article-title":"Plasma homocysteine levels are associated with peripheral neuropathy in patients with type 2 diabetes","volume":"54","author":"Idzior-Walus B","year":"2005","unstructured":"Idzior-Walus B, Sieradzki J, Walu\u015b-Miarka M, Cieslik G. Plasma homocysteine levels are associated with peripheral neuropathy in patients with type 2 diabetes. Diabetes. 2005, 54:A8.","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.4.859","article-title":"Microvascular disease and dementia in the elderly: are they related to hyperhomocysteinemia?","volume":"71","author":"Weir DG","year":"2000","unstructured":"Weir DG, Molloy AM. Microvascular disease and dementia in the elderly: are they related to hyperhomocysteinemia?. Am J Clin Nutr. 2000, 71:859-60. 10.1093\/ajcn\/71.4.859","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2003.12.003","article-title":"Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2","volume":"19","author":"de Luis DA","year":"2005","unstructured":"de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005, 19:42-6. 10.1016\/j.jdiacomp.2003.12.003","journal-title":"J Diabetes Complications"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5551\/jat.63849","article-title":"Hyperhomocysteinemia increases vascular risk in stroke patients with chronic kidney disease","volume":"30","author":"Mizuno T","year":"2023","unstructured":"Mizuno T, Hoshino T, Ishizuka K, et al.. Hyperhomocysteinemia increases vascular risk in stroke patients with chronic kidney disease. J Atheroscler Thromb. 2023, 30:1198-209. 10.5551\/jat.63849","journal-title":"J Atheroscler Thromb"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-007-9671-7","article-title":"Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease","volume":"310","author":"Alam MA","year":"2008","unstructured":"Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, Vasisht S. Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem. 2008, 310:111-7. 10.1007\/s11010-007-9671-7","journal-title":"Mol Cell Biochem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02075-2","article-title":"The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in NHANES","volume":"60","author":"Li H","year":"2023","unstructured":"Li H, Liu C, Zhang J, et al.. The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in NHANES. Acta Diabetol. 2023, 60:907-16. 10.1007\/s00592-023-02075-2","journal-title":"Acta Diabetol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01560.x","article-title":"Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study","volume":"258","author":"Soedamah-Muthu SS","year":"2005","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med. 2005, 258:450-9. 10.1111\/j.1365-2796.2005.01560.x","journal-title":"J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2003.10.034","article-title":"Fasting homocysteine levels in adults with type 1 diabetes and retinopathy","volume":"341","author":"Saeed BO","year":"2004","unstructured":"Saeed BO, Nixon SJ, White AJ, Summerfield GP, Skillen AW, Weaver JU. Fasting homocysteine levels in adults with type 1 diabetes and retinopathy. Clin Chim Acta. 2004, 341:27-32. 10.1016\/j.cccn.2003.10.034","journal-title":"Clin Chim Acta"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2012.00408.x","article-title":"Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects","volume":"17","author":"Gonz\u00e1lez R","year":"2012","unstructured":"Gonz\u00e1lez R, Pedro T, Martinez-Hervas S, et al.. Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects. J Peripher Nerv Syst. 2012, 17:191-6. 10.1111\/j.1529-8027.2012.00408.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.94.15_supplement.318","article-title":"Homocysteine: a potential risk factor for peripheral neuropathy (318)","volume":"94","author":"Lin R","year":"2020","unstructured":"Lin R, Bumanlag F, Mehta A, Si X, Dun N, Luo J. Homocysteine: a potential risk factor for peripheral neuropathy (318). Neurology. 2020, 94:10.1212\/WNL.94.15_supplement.318","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/pteridines-2020-0025","article-title":"Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients","volume":"32","author":"Ye B","year":"2021","unstructured":"Ye B, Zhu X, Zeng Z, Ji Z, Ji M. Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients. Pteridines. 2021, 32:11-6. 10.1515\/pteridines-2020-0025","journal-title":"Pteridines"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4236\/jdm.2023.134024","article-title":"Association between hyperhomocysteinemia and microangiopathic complications (neuropathy and nephropathy) in subjects with type 1 and type 2 diabetes","volume":"13","author":"Barry N","year":"2023","unstructured":"Barry N, Gueye S, Djit\u00e9 M, et al.. Association between hyperhomocysteinemia and microangiopathic complications (neuropathy and nephropathy) in subjects with type 1 and type 2 diabetes. J Diabetes Mellitus. 2023, 13:325-39. 10.4236\/jdm.2023.134024","journal-title":"J Diabetes Mellitus"},{"key":"ref17","article-title":"Study of assessment of plasma homocysteine level in microvascular complications of type 2 diabetes mellitus","volume":"4","author":"Mundu PA","year":"2017","unstructured":"Mundu PA, Kumar B, Mitra JK, Kumar M, Sinha R. Study of assessment of plasma homocysteine level in microvascular complications of type 2 diabetes mellitus. Int J Contemporary Med Res. 2017, 4:879-83.","journal-title":"Int J Contemporary Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02913073","article-title":"Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration","volume":"21","author":"Abraham R","year":"2006","unstructured":"Abraham R, John MJ, Calton R, Dhanoa J. Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration. Indian J Clin Biochem. 2006, 21:95-100. 10.1007\/BF02913073","journal-title":"Indian J Clin Biochem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/17604.7518","article-title":"Association between serum B12 and serum homocysteine levels in diabetic patients on metformin","volume":"10","author":"Upadhyay TR","year":"2016","unstructured":"Upadhyay TR, Kothari N, Shah H. Association between serum B12 and serum homocysteine levels in diabetic patients on metformin. J Clin Diagn Res. 2016, 10:BC01-4. 10.7860\/JCDR\/2016\/17604.7518","journal-title":"J Clin Diagn Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358410-hyperhomocysteinemia-a-predictor-of-microvascular-complications-in-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:40:43Z","timestamp":1754934043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358410-hyperhomocysteinemia-a-predictor-of-microvascular-complications-in-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.89826","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}